266 related articles for article (PubMed ID: 9447503)
1. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
[TBL] [Abstract][Full Text] [Related]
2. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
Pollock BG; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Huber KA
Am J Geriatr Psychiatry; 2007 Nov; 15(11):942-52. PubMed ID: 17846102
[TBL] [Abstract][Full Text] [Related]
4. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
[TBL] [Abstract][Full Text] [Related]
5. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
[TBL] [Abstract][Full Text] [Related]
6. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Oechsner M; Korchounov A
Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
[TBL] [Abstract][Full Text] [Related]
7. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
De Deyn PP; Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Kurlan R; Cummings J; Raman R; Thal L;
Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
[TBL] [Abstract][Full Text] [Related]
9. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
10. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Freund-Levi Y; Jedenius E; Tysen-Bäckström AC; Lärksäter M; Wahlund LO; Eriksdotter M
Am J Geriatr Psychiatry; 2014 Apr; 22(4):341-8. PubMed ID: 24035407
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
12. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
Zaraa AS
Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
[No Abstract] [Full Text] [Related]
13. Duration of risperidone treatment for BPSD.
Snowdon J; Brodaty H; Ames D; Day S
Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
[No Abstract] [Full Text] [Related]
14. A structured trial of risperidone for the treatment of agitation in dementia.
Lavretsky H; Sultzer D
Am J Geriatr Psychiatry; 1998; 6(2):127-35. PubMed ID: 9581208
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for agitation and psychosis in dementia.
Tariot PN
J Clin Psychiatry; 1996; 57 Suppl 14():21-9. PubMed ID: 9024333
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
[TBL] [Abstract][Full Text] [Related]
18. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
[TBL] [Abstract][Full Text] [Related]
19. Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.
Lin YT; Hwang TJ; Shan JC; Chiang HL; Sheu YH; Hwu HG
J Formos Med Assoc; 2015 Feb; 114(2):147-53. PubMed ID: 25678176
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine-induced dystonia and agitation in Parkinson's disease with dementia: a case report.
Leey J; Setters B; Murphy P; Antimisiaris D; Miles T
J Am Geriatr Soc; 2009 May; 57(5):918-9. PubMed ID: 19470011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
